Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Advancing drug development in myelodysplastic syndromes.
Journal: Blood advances
Published: September 20, 2024
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: February 12, 2020
U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission.
Journal: The oncologist
Published: November 06, 2018
Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System.
Journal: Leukemia & lymphoma
Published: May 25, 2018
Ibrutinib-associated Pneumocystis jirovecii pneumonia.
Journal: American journal of hematology
Published: August 11, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026